Grantham, Mayo, Van Otterloo & Co (GMO)’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-93,300
Closed -$1.87M 714
2021
Q3
$1.87M Sell
93,300
-243,900
-72% -$5M 0.01% 466
2021
Q2
$6.78M Buy
+337,200
New +$7.21M 0.03% 295
2018
Q2
Sell
-10,700
Closed -$139K 589
2018
Q1
$139K Hold
10,700
﹤0.01% 558
2017
Q4
$147K Buy
+10,700
New +$145K ﹤0.01% 563

Other funds holding MPT

Grantham, Mayo, Van Otterloo & Co (GMO)'s MPT Position: Q4 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Medical Properties Trust (MPT) in Q4 2021, closing a stake of 93,300 shares — an estimated $1.87M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MPT in Q4 2017 and held it in 4 quarters. The position peaked at $6.78M in Q2 2021. 634 funds tracked by Wall St. Rank hold MPT as of Q4 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Medical Properties Trust position as of Q4 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 93,300 Medical Properties Trust shares in Q4 2021, an estimated $1.87M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Medical Properties Trust in Q4 2017 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Medical Properties Trust position peaked at $6.78M in Q2 2021.
  • 634 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2021, filed 11 Feb 2022.